Buy or sell Progyny stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Progyny Stock

Progyny combines service, data, science and technology to provide fertility solutions to self-insured employers

Founded

2008

Headquarters

New York NY, US

Total Funding

$99.5M

About Progyny Stock

Progyny is the leading fertility benefits company that combines service, science, technology and data to provide fertility solutions for self-insured employers. Progyny’s approach offers members a comprehensive value based treatment plan that is based on the latest medical science and technology. The benefit plans are designed to improve outcomes, shorten time to pregnancy and reduce total fertility-related costs. The mission is to be the industry leader in comprehensive and inclusive fertility benefits that help people have a child and achieve the best possible outcomes. They accomplish this through their commitment to science and through personalized support that is fueled by hope and accomplished with care.

Funding History

February 2012$20.0M
May 2012$18.0M
September 2013$5.5M
March 2015$18.3M
May 2015$3.8M
July 2015$3.0M
July 2016$14.7M
August 2016$1.2M
May 2017$10.0M
November 2017$5.0M

Management

Chief Financial Officer and Chief Operating Officer

Peter Anevski

Director, Communications & Strategy

Selena Yang

VP, People

Cassandra Pratt

President, Health Care Services

Karin Ajamni

Chief Executive Officer

David J. Schlanger

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Progyny or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 70K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo